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Maternal obesity-induced 
decreases in plasma, hepatic and 
uterine polyunsaturated fatty acids 
during labour is reversed through 
improved nutrition at conception
Ronan Muir1, Ge Liu5, Raheela Khan2, Anatoly Shmygol3, Siobhan Quenby4, Robert Alan 
Gibson5,6, Beverly Muhlhausler5,6 & Matthew Elmes  1
Maternal obesity is associated with prolonged and dysfunctional labour, potentially through decreased 
synthesis of prostaglandins that stimulate myometrial contractions. We assessed the impact of 
maternal obesity on concentrations of precursor fatty acids (FA) for prostaglandin synthesis and 
whether any changes could be reversed by improved nutrition post-conception. Wistar rats were fed 
control (CON) or High-Fat, High-cholesterol (HFHC) diets 6 weeks before mating. At conception half the 
dams switched diets providing 4 dietary groups: (1) CON, (2) HFHC, (3) CON-HFHC or (4) HFHC-CON. 
During parturition rats were euthanized and FA composition of plasma, liver and uterus determined. 
Visceral fat was doubled in rats exposed to the HFHC diet prior to and/or during pregnancy compared 
to CON. HFHC diet increased MUFAs but decreased omega-3 and omega-6 PUFAs in plasma and liver. 
Uterine omega-3 FA concentrations were halved in HFHC versus CON rats, but all other FAs were similar. 
Switching from HFHC to CON diet at conception restored all FA profiles to those seen in CON rats. The 
increased MUFA and decreased PUFA concentrations in obese HFHC dams may contribute to aberrant 
prostaglandin synthesis and dysfunctional myometrial activity and it may be possible to reverse these 
changes, and potentially improve labour outcomes, by improving nutrition at conception.
Between the years 1975–2014 global obesity levels have increased from 105 to 641 million people1. The UK level 
of obesity in women of reproductive age currently stands at 20% and is estimated to reach 50% by 20502 and 
this is associated with a parallel increase in the number of women entering pregnancy with a high BMI (Centre 
for Maternal and Child Enquiries (3). Maternal obesity increases the risk of gestational diabetes, pre-eclampsia, 
post-partum haemorrhage and prolonged and dysfunctional labour resulting in emergency caesarean deliv-
ery3–6. Although the increased risks of adverse pregnancy outcomes in obese women is well established, very few 
studies have attempted to elucidate the underlying mechanism(s), and therefore identify potential strategies for 
intervention.
Prostaglandins PGF2α, PGE2 and PGI2 produced within intrauterine tissues play a central role in regulating 
uterine activity during pregnancy and parturition7, and increased production of these compounds is required 
for the initiation and progression of labour. PGE2 maintains uterine quiescence during pregnancy but stimu-
lates myometrial contractions during labour via specific EP receptors8 whereas PGF2α stimulates myometrial 
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contractions9 and PGI2 primes the myometrium for enhanced contractile response10. These 2 series prostaglan-
dins are, in turn, derived from the omega-6 fatty acid arachidonic acid (AA 20:4 n-6). In contrast, the omega-3 
fatty acid, eicosapentaenoic acid (EPA 20:5 n-3) gives rise to the 3 series prostaglandins, which are less biolog-
ically active and thus reduce uterine contractility and delay parturition. AA is either acquired from the diet or 
synthesized de novo from the precursor n-6 PUFA linoleic acid (LA, 18:2 n-6)11,12.
The fact that the omega-3 and omega-6 fats give rise to PGs with distinct biological activities has led to sug-
gestions that the dietary balance of omega-6 and omega-3 fatty acids may play a key regulatory role in labour 
and parturition, particularly the physiological processes requiring prostaglandin synthesis. This is supported by 
human and animal studies that have shown a significant increase in the risk of premature labour when humans 
or animal consume diets rich in n-6 PUFA13,14. In contrast, diets high in n-3 PUFA significantly prolong gesta-
tion and labour15–20. Dietary alteration of prostaglandin synthesis has been proposed to occur through n-3 and 
n-6 PUFAs, such as DGLA (20:3, n-6) and EPA competing with AA for incorporation into phospholipids of 
the plasma membrane21,22 but also processing by desaturase23,24 and COX-2 enzymes that synthesise long chain 
PUFAs and prostaglandins respectively.
The role of altered fatty acid composition as a contributing factor to the increased risk of pregnancy com-
plications in obese women has not been previously explored. This is despite clear evidence of the importance 
of dietary fatty acids in regulating the physiology and endocrinology of female reproduction and the timing 
and length of labour25, and evidence of altered prostaglandin production in the context of maternal obesity. We 
have recently established that plasma levels of PGF2α during labour are significantly lower in obese high-fat, 
high-cholesterol (HFHC) fed rats compared to lean controls26 suggesting that maternal obesity is associated with 
a decreased capacity for PGF2α synthesis. In addition, modulation of both monounsaturated fatty acids (MUFAs) 
and omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) have been reported to affect the timing of partu-
rition27–29 and may thus play a key role in the prolonged and dysfunctional labour often associated with maternal 
obesity4.
Consequently, the aim of the present study was to investigate the effects of dietary HFHC induced maternal 
obesity on plasma, hepatic and uterine fatty acid composition during labour, with a particular focus on the pre-
cursor fatty acids for prostaglandin synthesis. A second aim was to ascertain whether changing diet at conception 
can improve the n-6 fatty acid status and increase the capacity for PGF2α synthesis, and thus identify a potential 
intervention for reducing the risk of prolonged and dysfunctional labour associated with maternal obesity.
Results
Body and Fat Depot Weights. Feeding a HFHC diet for 6 weeks prior to mating was associated with a 
significant increase in body weight at conception (Fig. 1A). There was no difference in gestational weight gain 
between the 4 treatment groups (Fig. 1B). At the time of parturition, however, rats fed the HFHC diet before mat-
ing were still significantly heavier than rats fed the CON diet before mating, independent of their diet post-con-
ception (P < 0.05). Body weight of the rats fed the CON diet before mating, but switched to the HFHC diet 
at conception (CON-HFHC) at the end of gestation was not different to those in any other treatment group 
(Fig. 1C). Visceral fat mass (sum of perirenal and gonadal fat) was 2-fold higher in rats exposed to the HFHC diet 
either before and/or post-conception compared to the CON group (Fig. 2).
Fatty acid composition of the plasma. The fatty acid profile of the plasma collected from rats fed a CON 
or HFHC diet for 6 weeks prior to and during pregnancy and those whose diet was switched at conception is 
presented in Table 1.
Saturated and monounsaturated fatty acids. Total plasma saturated fatty acid levels at partition were higher in 
the HFHC-CON group compared to all other dietary treatments (P < 0.009), but were not different between the 
CON, HFHC and CON-HFHC groups. Analysis of the individual saturated fatty acids identified that exposure 
to a HFHC either during the entire period, or only post-conception, was associated with significant increases in 
levels of myristic acid (14:0) and pentadecylic acid (15:0) in comparison to the CON group. These increases were 
partially (in the case of pentadecylic acid) or completely (in the case of myristic acid) normalised by switching 
rats fed a HFHC diet before mating to a CON diet after conception. Conversely, plasma levels of stearic (18:0) 
and behenic Acid (22:0) were lower in the CON-HFHC and HFHC rats when compared to CON, but were not 
different between the HFHC-CON and CON treatment groups.
Total plasma monounsaturated fatty acid concentrations, as well as concentrations the major omega-9 and 
-7 monounsaturated fatty acids, oleic acid (18:1 n-9) and palmitoleic acid (16:1 n-7), were increased by 3-fold in 
rats exposed to HFHC vs CON diet during the post-conception period, independent of their diet prior to mating 
(Table 1). Plasma concentrations of vaccenic acid (18:1 n-7), however, were not different between CON, a HFHC, 
and CON-HFHC dietary groups, but were lower in the CON-HFHC and HFHC-CON fed rats compared to those 
exposed to the HFHC diet during both the pre-conception and post-conception periods.
Omega-3 and omega-6 polyunsaturated fatty acids. Plasma total omega-3 PUFA levels at parturition were lower 
in rats fed the HFHC diet post-conception, independent of their diet before mating (Table 1). The same pattern 
was also observed for the individual omega-3 LCPUFA, EPA and DHA. Thus, feeding rats the HFHC diet during 
gestation was associated with reduced plasma EPA and DHA contents, however switching rats from a HFHC 
diet to a CON diet post-conception ameliorated these effects (Table 1). In the case of ALA, there appeared to be 
a dose-response relationship between HFHC exposure and plasma concentrations, such that plasma levels were 
lowest in rats fed the HFHC diet both before and after conception, highest in rats fed the CON diet during both 
periods and intermediate in the other two treatment groups (Table 1).
www.nature.com/scientificreports/
3SCieNtifiC REpoRtS |  (2018) 8:3389  | DOI:10.1038/s41598-018-21809-9
Total Omega-6 PUFA concentrations and concentrations of the omega-6 LCPUFA, AA, followed a similar pat-
tern, and were lower in rats exposed to the HFHC diet compared to the CON diet post-conception (All P ≤ 0.007). 
Plasma LA (18:2 n-6), concentrations were lower in rats fed the HFHC diet either pre- or post-conception com-
pared to the CON group, and were not restored to CON levels by switching HFHC rats to the CON diet after 
mating.
Fatty acid composition of the liver. Saturated and monounsaturated fatty acids. The fatty acid compo-
sition of the liver followed a similar pattern to that of the plasma (Table 2). Total saturated fat content was lower 
in rats exposed to the HFHC diet post-conception, independent of their diet prior to mating. Exposure to the 
HFHC diet post-conception increased liver myristic (14:0) and pentadecyclic (15:0) acid contents ≥ 2-fold when 
compared to CON, and switching from a HFHC to control diet post-conception completely reversed this effect 
in HFHC-CON animals. Liver palmitic acid (C16:0) content was lower in rats in the CON-HFHC vs CON treat-
ment groups, but was not different between the CON, HFHC and HFHC-CON groups. Stearic (18:0), behenic 
(22:0) and lignoceric (24:0) acid were also lower in rats fed a HFHC diet post-conception, but were not different 
between the HFHC-CON and CON groups.
Figure 1. Bodyweight changes 6 weeks before mating (A) during pregnancy (B) and final weight at term 
pregnancy (C) in rats fed either a CON, HFHC, CON-HFHC or HFHC-CON diet. Values are means with SEM 
represented by vertical bars. Dietary treatment groups with different superscript letters are significantly different 
at the P < 0.05 level.
Figure 2. The effects of feeding a CON, HFHC, CON-HFHC or HFHC-CON diet on maternal total visceral fat 
depot weights at term pregnancy. Values are means with SEM represented by vertical bars. Dietary treatment 
groups with different superscript letters are significantly different at the P < 0.05 level.
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The most substantial shifts in hepatic fatty acid composition were observed in the monounsaturated fatty acid 
fraction, with total hepatic monounsaturated fatty acid content increased more than 4-fold in rats fed the HFHC 
diet post-conception, independent of their diet before mating (Table 2). Hepatic monounsaturated fatty acid 
content in rats switched from a HFHC diet to a control diet at conception was, however, not different to the CON 
group. Hepatic omega-9 and omega-7 monounsaturated fatty acid contents within the liver followed a similar pat-
tern to total monounsaturated fatty acid contents. The individual omega-9 and omega-7 monounsaturated fatty 
acids significantly altered by diet in this way were oleic (18:1 n-9) and palmitoleic acids (16:1 n-7). Interestingly, 
the omega 7 fatty acid vaccenic acid (18:1, n-7) did not follow the same trend, and concentrations of this fatty acid 
were higher in HFHC rats in comparison to the CON, CON-HFHC, and HFHC-CON dietary groups.
Omega-3 and omega-6 polyunsaturated fatty acids. Hepatic total omega-3 content was 4-fold lower in rats fed 
the HFHC diet post-conception, compared to both the CON and HFHC-CON groups (Table 2). Rats switched 
from the control to HFHC diet at conception (CON-HFHC) had a hepatic omega-3 content that was intermediate 
between the HFHC-CON, CON and HFHC groups (Table 2). There was no effect of the HFHC diet on hepatic 
ALA concentrations, but concentrations of EPA, DPA and DHA were all lower in rats exposed to the HFHC diet 
after conception compared to the CON treatment group. In particular, DHA levels were reduced approximately 
5-fold in HFHC fed rats compared to the CON group. Rats that were switched from a CON to HFHC diet at 
conception had lower EPA, DHA and DPA contents than CON rats, but DPA and DHA levels were still signifi-
cantly higher than in rats fed the HFHC diets both before and after conception (HFHC). Conversely, EPA, DPA 
and DHA concentrations in rats switched from a HFHC diet to a CON diet at conception were similar to those 
in CON animals.
Total hepatic omega 6 polyunsaturated fatty acid levels of the liver were approximately 5% lower in HFHC rats 
compared to the CON group, but was not different between the CON, CON-HFHC, and HFHC-CON groups. In 
terms of individual omega-6 fatty acids, gamma linoleic (18:3 n-6) and di-homo-gamma-linoleic (20:3 n-6) acid 
were not significantly different among the 4 dietary groups, while other major omega-6 PUFA were significantly 
altered. Thus, hepatic LA content was increased in rats exposed to a HFHC diet post-conception when compared 
Plasma
CONTROL 
(n = 5) HFHC (n = 6)
CONTROL-HFHC 
(n = 6)
HFHC-CONTROL 
(n = 5)
P valueMean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Total Saturates 34.45 ± 0.53A 33.83 ± 0.40A 33.32 ± 0.75A 36.04 ± 0.26B 0.009
14:0 0.36 ± 0.01A 1.39 ± 0.12B 1.36 ± 0.16B 0.53 ± 0.04A <0.0001
15:0 0.20 ± 0.01A 0.38 ± 0.02B 0.37 ± 0.02B 0.27 ± 0.01C <0.0001
16:0 20.40 ± 0.75 21.01 ± 0.25 20.10 ± 0.67 20.70 ± 0.23 0.592
17:0 0.44 ± 0.03 0.54 ± 0.05 0.48 ± 0.05 0.46 ± 0.01 0.260
18:0 11.85 ± 0.95A 9.67 ± 0.30B 10.22 ± 0.15B 12.71 ± 0.25A 0.001
20:0 0.14 ± 0.02 0.13 ± 0.02 0.13 ± 0.01 0.16 ± 0.02 0.919
22:0 0.24 ± 0.03A 0.13 ± 0.02B 0.13 ± 0.01B 0.25 ± 0.01A 0.010
24:0 0.22 ± 0.02 0.14 ± 0.02 0.15 ± 0.01 0.22 ± 0.01 0.166
Total Monos 9.39 ± 0.96A 27.10 ± 1.33B 24.28 ± 2.30B 9.58 ± 0.31A <0.0001
Total Omega 9 7.57 ± 0.91A 23.53 ± 0.97B 21.37 ± 2.04B 7.75 ± 0.26A <0.0001
18:1n-9 7.51 ± 0.90A 23.37 ± 0.96B 21.24 ± 2.04B 7.75 ± 0.26A <0.0001
20:1n-9 0.10 ± 0.02A 0.16 ± 0.02B 0.13 ± 0.01B — <0.0001
Total Omega 7 1.81 ± 0.08A 3.57 ± 0.41B 2.91 ± 0.28B 1.83 ± 0.07A <0.0001
16:1n-7 0.70 ± 0.06A 2.36 ± 0.37B 1.86 ± 0.22B 0.84 ± 0.09A <0.0001
18:1n-7 1.11 ± 0.04AB 1.21 ± 0.04A 1.05 ± 0.05BC 0.99 ± 0.03C 0.005
Total Omega 3 9.77 ± 0.68A 3.03 ± 0.33B 4.49 ± 0.35C 8.99 ± 0.34A <0.0001
18:3n-3 1.12 ± 0.12A 0.38 ± 0.03B 0.62 ± 0.04C 0.85 ± 0.06D <0.0001
20:5n-3 0.19 ± 0.02AB 0.08 ± 0.01C 0.11 ± 0.02BC 0.17 ± 0.03A 0.007
22:5n-3 1.05 ± 0.12A 0.31 ± 0.07B 0.44 ± 0.11B 0.77 ± 0.02C <0.0001
22:6n-3 7.42 ± 0.62A 2.25 ± 0.28B 3.34 ± 0.30B 7.20 ± 0.33A <0.0001
Total Omega 6 46.35 ± 0.80A 35.20 ± 1.17B 36.92 ± 1.69B 45.23 ± 0.38A <0.0001
18:2n-6 22.02 ± 1.48A 17.28 ± 0.31B 19.02 ± 0.61B 19.17 ± 0.66B 0.008
18:3n-6 0.59 ± 0.05 0.49 ± 0.05 0.53 ± 0.05 0.65 ± 0.04 0.210
20:2n-6 0.26 ± 0.01AC 0.20 ± 0.02B 0.20 ± 0.01B 0.23 ± 0.03BC 0.045
20:3n-6 0.44 ± 0.05 0.48 ± 0.02 0.41 ± 0.03 0.44 ± 0.03 0.412
20:4n-6 18.39 ± 1.2A 11.57 ± 0.81B 12.71 ± 1.01B 19.63 ± 0.70A <0.0001
Table 1. A comparison of the fatty acid composition of maternal plasma from rats fed either a control chow 
(CONTROL), High-Fat, High-Cholesterol (HFHC), CON-HFHC, or HFHC-CON diet. Control and HFHC 
diets were fed 6 weeks prior to and during the whole of pregnancy. CON-HFHC and HFHC-CON exposed 
rats were fed CONTROL and HFHC diets prior to pregnancy but then switched to HFHC and CON diets at 
conception respectively and maintained on the switched diet until parturition.
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to CON rats, but was not different between the HFHC-CON and CON groups. In contrast, exposure to the HFHC 
diet during pregnancy significantly decreased hepatic levels of both eicosadienoic (20:2, n-6) and AA when com-
pared to the CON group, but were not different between the HFHC-CON and CON groups. Interestingly there 
also appeared to be a dose-response relationship between the duration of HFHC exposure and hepatic AA con-
centrations, such that levels were lowest in rats fed the HFHC diet both before and after conception, highest in 
rats fed the CON diet during both periods and intermediate in the CON-HFHC and HFHC-CON groups.
Fatty acid composition of the uterus. Uterine composition of fatty acids are presented in Table 3. The 
uterus was particularly resistant to any change in fatty acid composition, and there were no differences in the 
content of saturated, monounsaturated or omega-6 polyunsaturated fatty acids between the 4 treatment groups. 
Total omega-3 fatty acid content in the uterine horn was, however, ~2-fold lower in the HFHC group compared 
to the CON group (P < 0.022). Importantly, rats switched from a HFHC diet to a control diet at conception had 
omega-3 fatty acid concentrations in their uterine horn that were not different from the CON group. The shifts in 
uterine omega-3 concentrations appeared to be driven primarily by changes in DHA, which tended (P = 0.095) to 
follow a similar pattern to that for total omega-3 concentration (Table 3).
Discussion
The overall aim of the current study was to investigate the effects of HFHC feeding to induce obesity and its 
subsequent effects on the fatty acid composition of the plasma, liver and uterus. As expected, feeding the HFHC 
diet significantly increased the weight of the dams both pre-gestation and during pregnancy. The increases in 
bodyweight was attributed to significant increases in the accumulation of visceral fat, which was twice as high in 
rats exposed to the HFHC diet either before or after conception compared to rats fed a control diet during this 
entire period.
With confirmation that the HFHC diet causes maternal obesity, we wanted to determine its impact on plasma, 
hepatic and uterine fatty acid composition and whether it can be reversed by a dietary change at conception. 
Liver
CONTROL 
(n = 5) HFHC (n = 6)
CONTROL-HFHC 
(n = 6)
HFHC-CONTROL 
(n = 5)
P valueMean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Total Saturates 43.45 ± 0.77A 34.48 ± 0.73B 35.63 ± 0.90B 42.94 ± 0.63A <0.0001
14:0 0.43 ± 0.02A 1.32 ± 0.31B 0.97 ± 0.08B 0.52 ± 0.12A 0.016
15:0 0.19 ± 0.02A 0.33 ± 0.03B 0.30 ± 0.02B 0.18 ± 0.02A 0.002
16:0 22.48 ± 0.83A 21.96 ± 0.24AB 20.86 ± 0.35B 21.73 ± 0.62AB 0.007
17:0 0.45 ± 0.03 0.45 ± 0.03 0.43 ± 0.02 0.43 ± 0.02 0.833
18:0 17.91 ± 0.77A 9.61 ± 0.45B 12.17 ± 0.63C 18.61 ± 0.62A <0.0001
20:0 0.20 ± 0.04 0.13 ± 0.03 0.11 ± 0.02 0.19 ± 0.08 0.615
22:0 0.40 ± 0.04A 0.14 ± 0.03B 0.17 ± 0.03BC 0.29 ± 0.09AC 0.026
24:0 0.38 ± 0.03A 0.16 ± 0.02B 0.20 ± 0.03B 0.32 ± 0.04A <0.0001
Total Monos 6.94 ± 0.32A 31.02 ± 1.87B 23.89 ± 1.60C 7.03 ± 0.49A <0.0001
Total Omega 9 4.89 ± 0.24A 27.29 ± 1.62B 21.19 ± 1.54C 5.27 ± 0.43A <0.0001
18:1n-9 4.58 ± 0.31A 27.01 ± 1.63B 20.98 ± 1.52C 5.06 ± 0.41A <0.0001
20:1n-9 — 0.21 ± 0.01 0.15 ± 0.01 0.10 ± 0.03 0.072
22:1n-9 — 0.07 ± 0.02 0.08 ± 0.02 0.13 ± 0.06 0.344
Total Omega 7 1.92 ± 0.08A 3.67 ± 0.32B 2.66 ± 0.08C 1.66 ± 0.04A <0.0001
16:1n-7 0.65 ± 0.08A 2.15 ± 0.28B 1.43 ± 0.07C 0.48 ± 0.03A <0.0001
18:1n-7 1.27 ± 0.06A 1.52 ± 0.07B 1.24 ± 0.03A 1.18 ± 0.04A 0.010
Total Omega 3 13.99 ± 0.46A 3.30 ± 0.44B 5.91 ± 0.34C 13.02 ± 0.49A <0.0001
18:3n-3 0.49 ± 0.06 0.31 ± 0.03 0.43 ± 0.06 0.45 ± 0.05 0.100
20:5n-3 0.17 ± 0.02A 0.07 ± 0.02B 0.10 ± 0.01BC 0.15 ± 0.03AC 0.014
22:5n-3 1.14 ± 0.08A 0.30 ± 0.07B 0.49 ± 0.08C 0.92 ± 0.02A <0.0001
22:6n-3 12.19 ± 0.45A 2.62 ± 0.37B 4.89 ± 0.44C 11.50 ± 0.50A <0.0001
Total Omega 6 35.60 ± 0.58AC 30.39 ± 1.16B 33.64 ± 0.69A 36.75 ± 0.61C <0.0001
18:2n-6 13.08 ± 0.56A 15.65 ± 0.40B 16.14 ± 1.20B 11.86 ± 0.39A 0.001
18:3n-6 0.56 ± 0.13 0.46 ± 0.07 0.49 ± 0.07 0.61 ± 0.16 0.858
20:2n-6 0.45 ± 0.05A 0.24 ± 0.01B 0.27 ± 0.02B 0.43 ± 0.06A 0.008
20:3n-6 0.52 ± 0.05 0.40 ± 0.04 0.39 ± 0.04 0.38 ± 0.08 0.241
20:4n-6 14.32 ± 0.64A 7.89 ± 0.48B 10.77 ± 0.59C 15.88 ± 0.62A <0.0001
Table 2. A comparison of the fatty acid composition of maternal liver from rats fed either a control chow 
(CONTROL), High-Fat, High-Cholesterol (HFHC), CON-HFHC, or HFHC-CON diet. Control and HFHC 
diets were fed 6 weeks prior to and during the whole of pregnancy. CON-HFHC and HFHC-CON exposed 
rats were fed CONTROL and HFHC diets prior to pregnancy but then switched to HFHC and CON diets at 
conception respectively and maintained on the switched diet until parturition.
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What is evident from the current study is that exposure to the HFHC diet significantly alters the fatty acid profile 
of the plasma, liver and, to a more limited extent, the uterus. The fatty acid profile of both the plasma and liver 
from HFHC fed rats was characterised by significant increases in MUFAs with parallel decreases in total omega-3 
and omega-6 PUFAs when compared to CON fed rats, findings consistent with previous studies utilising mater-
nal high fat diets in rats and non-human primates30,31 as well as the fatty acid status of obese adults32,33 and obese 
pregnant women at mid-gestation34. Critically, we have established that switching diets at conception from a CON 
or HFHC diet and feeding a HFHC or CON diet during pregnancy respectively, reversed the plasma fatty acid 
profiles, such that these mirrored those of the post-conception diets. This suggests that alterations in circulating 
and hepatic fatty acid composition in rats consuming an obesogenic HFHC diet before conception, can be favour-
ably altered by switching to a CON diet during pregnancy.
One intriguing finding was that exposure to a HFHC diet significantly altered the fatty acid profiles of the 
plasma and liver, but induced very little change in the uterus. The uterus only differed in total omega-3 fatty acids, 
which was reduced by half by the HFHC diet, and this effect was reversed when rats were switched to a CON diet 
post-conception. It is plausible that the uterus could be resistant to changes in dietary fatty acids, similar to the 
brain35. A further possibility could be that by collecting tissue from labouring animals the fatty acids within the 
uterus necessary for labour had been utilised, and differences may only be apparent prior to the onset of labour. 
Nevertheless, a decrease in omega-3 fatty acids in the uterus following feeding of the HFHC diet has the potential 
to compromise uterine CAP expression by altering the fluidity of the plasma membrane4. Fatty acids play a vital 
role in the formation of the plasma membrane lipid bilayer, and increases in membrane PUFA content is associ-
ated with increased membrane fluidity, which in turn affects the expression, function, and downstream signalling 
of integral proteins35. This theory is supported by the findings of de Jonge et al.36 where the membrane fluidity of 
cultured rat ventricular myocytes decreases following incorporation of the omega-3 fatty acid EPA and that this 
is associated with increases in the regularity of their spontaneous contractions. It was also evident in the same 
study that ventricular myocytes treated with endothelin 1 to stimulate a phospholipase-C β response (PLC- β) was 
significantly increased following EPA treatment when compared to myocytes grown in control medium. These 
Uterus
CONTROL 
(n = 5) HFHC (n = 6)
CONTROL-HFHC 
(n = 6)
HFHC-CONTROL 
(n = 5)
P valueMean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM
Total Saturates 40.6 ± 5.2 46.1 ± 1.7 45.2 ± 4.6 44.7 ± 3.5 0.6530
14:0 1.3 ± 0.3 2.2 ± 0.3 1.7 ± 0.2 1.6 ± 0.2 0.0980
15:0 0.3 ± 0.0 0.5 ± 0.1 0.5 ± 0.1 0.4 ± 0.0 0.2090
16:0 24.3 ± 1.2 23.9 ± 1.2 23.0 ± 0.8 24.4 ± 0.9 0.9090
17:0 1.1 ± 0.3 1.0 ± 0.2 1.2 ± 0.3 1.0 ± 0.2 0.6710
18:0 5.4 ± 3.1 10.8 ± 2.8 10.5 ± 3.1 9.4 ± 3.7 0.6470
20:0 0.8 ± 0.3 0.7 ± 0.1 0.9 ± 0.2 0.8 ± 0.1 0.5560
22:0 1.6 ± 0.5 1.4 ± 0.3 1.5 ± 0.4 1.4 ± 0.3 0.9000
24:0 1.3 ± 0.4 1.2 ± 0.3 1.3 ± 0.4 1.3 ± 0.3 0.8860
Total Monos 15.2 ± 2.8 17.2 ± 2.4 15.1 ± 1.9 15.3 ± 3.4 0.8540
Total Omega 9 12.5 ± 2.4 14.3 ± 2.1 13.0 ± 1.4 12.2 ± 2.9 0.8800
18:1n-9 12.4 ± 2.3 14.2 ± 2.0 12.8 ± 1.3 12.1 ± 2.8 0.2110
20:1n-9 0.3 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.6550
22:1n-9 — 0.1 ± 0.2 0.2 ± 0.0 — 0.5340
Total Omega 7 2.7 ± 0.5 2.8 ± 0.4 2.1 ± 0.6 3.1 ± 0.5 0.3100
16:1n-7 1.1 ± 0.2 1.6 ±0.3 1.2 ± 0.3 1.5 ± 0.4 0.4210
18:1n-7 1.8 ± 0.2 1.5 ± 0.1 1.6 ± 0.2 1.8 ± 0.1 0.1330
Total Omega 3 4.8 ± 0.7A 2.8 ± 0.3B 4.1 ± 0.2AB 4.2 ± 0.5A 0.0220
18:3n-3 0.9 ± 0.4 0.6 1.1 ± 0.4 0.6 ± 0.1 0.1990
20:5n-3 0.2 ± 0.1 0.2 ± 0.0 0.2 ± 0.0 0.4 ± 0.2 0.5140
22:5n-3 0.9 ± 0.1 0.8 ± 0.1 1.0 ± 0.1 0.8 ± 0.1 0.3040
22:6n-3 3.1 ± 0.7 1.8 ± 0.2 2.3 ± 0.1 3.2 ± 0.5 0.0950
Total Omega 6 39.2 ± 2.8 33.0 ± 1.3 34.7 ± 2.6 35.4 ± 2.2 0.2450
18:2n-6 15.0 ± 4.8 9.1 ± 1.3 13.1 ± 3.2 10.5 ± 2.0 0.4680
18:3n-6 2.2 ± 0.7 1.7 ± 0.4 1.5 ± 0.2 1.5 ± 0.3 0.7580
20:2n-6 0.9 ± 0.1 0.6 ± 0.1 0.6 ± 0.0 0.8 ± 0.1 0.1600
20:3n-6 2.4 ± 0.6 2.0 ± 0.4 2.2 ± 0.7 1.6 ± 0.2 0.6490
20:4n-6 12.5 ± 3.0 12.2 ± 1.2 11.2 ± 1.1 13.7 ± 1.9 0.9210
Table 3. A comparison of the fatty acid composition of uterine horn from rats fed either a control chow 
(CONTROL), High-Fat, High-Cholesterol (HFHC), CON-HFHC, or HFHC-CON diet. Control and HFHC 
diets were fed 6 weeks prior to and during the whole of pregnancy. CON-HFHC and HFHC-CON exposed 
rats were fed CONTROL and HFHC diets prior to pregnancy but then switched to HFHC and CON diets at 
conception respectively and maintained on the switched diet until parturition.
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research findings are significant in respect to the current study because endothelin-1 causes potent constriction 
of myometrial strips from term human pregnancies37 and the PLC signalling pathway plays an important role 
in regulating uterine contractile activity. As a result, a plausible deduction would be that the halving of the total 
omega-3 fatty acids within the uterus following exposure to the HFHC diet could be playing a key role in the 
un-coordinated ex vivo contractions previously observed in our maternal obesity model38.
An additional mechanism through which fatty acids can impact on the physiology of female reproduction is 
through alterations in prostaglandin synthesis, particularly synthesis of the 2 series prostaglandins PGF2α and 
PGE2 which can both stimulate8,39 and relax8 myometrial contractions respectively. The omega-6 PUFA AA is 
the direct precursor for synthesis of the 2 series prostaglandins and there is vast evidence to show that dietary 
manipulation of omega-6 PUFAs can impact on PGF2α and PGE2 production during pregnancy. Pregnant sheep 
fed a diet high in the essential omega-6 PUFA linoleic acid (LA) significantly increased the level of AA within 
plasma and placental tissues which was associated with a significant increases in both PGF2α and PGE2 synthesis29 
and an increased risk of premature labour13. In contrast, dietary supplementation with omega-3 PUFAs the fatty 
acid precursors for synthesis of the less potent 3-series prostaglandins PGF3α and PGE3 reduces premature birth 
rates40. Furthermore, continual intravenous infusion of fish oil concentrate to pregnant ewes has been shown to 
delay and occasionally prevent glucocorticoid-induced preterm delivery15. Not surprisingly there has long been 
an interest in the use of n-3 PUFA as an effective tocolytic agent in human pregnancy. Using our model of mater-
nal obesity we have provided evidence that a HFHC diet causes a significant reduction in plasma levels of PGF2α 
during labour26 and poorly coordinated myometrial contractions ex vivo38. This significant decrease in plasma 
PGF2α is a result of HFHC animals consuming a diet 33% lower in the availability of LA, which translates to the 
lower circulating levels of the prostaglandin precursor AA identified in this report (CON 18.39% ± 1.20 vs HFHC 
11.57% ± 0.81; P < 0.0001). Essentially, the current study provides evidence that changing diet at conception from 
a HFHC to CON diet can reverse these effects and increase the plasma level of AA (HFHC-CON 19.63% ± 0.70) 
thereby increasing the capacity for prostaglandin synthesis and potentially improvement of labour outcomes with 
maternal obesity.
One of most dramatic changes observed in the current study was that following exposure to a HFHC diet there 
was a significant 3- & 5-fold increase in the plasma and hepatic levels of the MUFA oleic acid (18:1 n-9) respec-
tively. Very little research has investigated the specific effects of oleic acid on prostaglandin production. However, 
one recently published study suggests oleic acid could also contribute to the decrease in plasma PGF2α observed 
in our maternal obesity model26. Primary culture of endometrial cells from late pregnant ewes showed that oleic 
acid supplementation favoured PGE2 production and attenuated PGF2α synthesis even in the presence of the 
prostaglandin synthesis stimulator oxytocin27. Interestingly, the authors speculated that raised circulating levels of 
oleic acid may affect the initiation and progress of parturition and could also offer a further potential mechanism 
behind the dysfunctional labour associated with maternal obesity. If future research can confirm inhibitory effects 
of oleic acid, on PGF2α production then the current study shows clearly that high circulatory and hepatic levels of 
oleic acid caused by consumption of a HFHC diet can be decreased very easily by changing the composition of the 
diet consumed during pregnancy. This in turn could increase the capacity for PGF2α synthesis.
It is important to consider that changes in fatty acid composition may compromise uterine contractile activity 
through mechanisms other than prostaglandin synthesis. One potential mechanism is the direct effect of fatty 
acids on uterine expression of key contraction-associated proteins (CAPs). One such protein is connexin-43 
(Cx-43), which is essential for formation of gap junctions that act as intracellular conduits to facilitate cell-cell 
electro-coupling (synchronisation of muscular contractions) and metabolite transfer41. Loss of expression of 
Cx-43 is associated with dysfunctional myometrial contractile activity and prolonged labour41–44. Our previ-
ous research identified that exposure to a HFHC significantly decreases uterine expression of Cx-43 during 
labour26,38. Quantification of the phosphorylated form of Cx-43 (pCX-43, phosphorylation at serine 368) was 
significantly higher in labouring HFHC fed rats compared to controls38. This is an important observation as 
phosphorylation of CX-43 compromises gap junction assembly, trafficking, and intracellular communication45. 
Interestingly, cardiomyocyte contractile activity is significantly decreased when exposed to oleic acid in vitro by 
inducing gap junction disassembly as a result of phosphorylation of CX-43 by protein kinase C (PKC)46. Thus, the 
increased circulating and hepatic oleic acid levels observed in rats fed the HFHC diet in the present study could 
potentially contribute to the decrease in Cx-43 and increase in pCx-43 previously observed in the labouring uteri 
of our HFHC fed rats38.
To summarize, exposure to a HFHC diet to induce obesity resulted in significant shifts in plasma and hepatic 
fatty acid composition, but only altered levels of omega-3 fats in the uterus. HFHC feeding was associated with 
significant increases in MUFAs and parallel decreases in total omega-3 and omega-6 PUFAs in both the plasma 
and liver. In contrast the uterus was more resistant to changes in dietary fatty acid incorporation, but the uteri 
from HFHC exposed rats did exhibit a significant decrease in the total omega-3 fatty acids. What is very clear 
from the fatty acid profile of HFHC fed animals is that the diet has the capacity to detrimentally alter prostaglan-
din synthesis, membrane fluidity, and uterine contractile protein expression. All of the aforementioned mecha-
nisms may play a role in prolonged and dysfunctional labour associated with maternal obesity. Of key importance 
is the evidence that changing from a HFHC to CON diet at conception with the absence of any reduction in 
maternal fat mass, reverses the fatty acid profile associated with obesity and has the potential to improve uterine 
contractile activity and labour outcome.
Although change of diet at conception to improve labour outcomes in obese pregnancies may be an effective 
approach, further research is required to determine the effects of the HFHC diet and change of diet at conception 
on (1) prostaglandin synthesis, (2) uterine expression of the key contractile associated proteins and (3) myome-
trial excitation-contraction coupling and contractility both ex vivo and in vivo.
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Materials and Methods
Animals and Experimental Design. All animal experiments were performed in accordance with the rele-
vant laws and institutional guidelines and were approved by the University of Nottingham Animal Welfare Ethical 
Review Board (AWERB) and the UK Home Office [Project licence code (PPL) 40/3598]. All procedures were 
carried out by licenced researchers under the Animals in Scientific Procedures Act (ASPA) of 1986 within the 
animal facilities of the University of Nottingham.
A total of 22 weanling virgin female Wistar rats (Rattus rattus) weighing approximately 60 g (Charles River, 
UK) were pair housed under normal conditions (12 hour light: dark photoperiod, 21 °C ± 5 °C room temperature, 
55% ± 5% relative humidity, food and water access ad libitum) and randomly assigned to be fed either a standard 
control laboratory chow (CON, n = 11) (Harlan Laboratories, UK) or High-Fat, High-Cholesterol diet (HFHC, 
n = 11) as detailed in Table 4. Nutritional breakdown and fatty acid composition of the CON and HFHC diets are 
also provided in Tables 5 and 6. Rats were pair housed and maintained on their respective diets for 6 weeks prior 
to mating with stud Wistar males (Charles River, UK). Pregnancy was confirmed upon discovery of a semen plug 
and was recorded as gestational day 0. Once conception was confirmed half of the rat dams from each dietary 
group were switched to the alternate diet throughout pregnancy, such that CON fed rats were switched to a HFHC 
diet and HFHC fed rats to a CON chow diet respectively. This provided 4 experimental treatment groups: (1) 
CON (n = 5), (2) HFHC (n = 6), (3) CON-HFHC (n = 6) or (4) HFHC-CON (n = 5) diet.
All pregnant rats were then individually housed and maintained on their respective diet throughout gestation. 
Daily food intake and weight gain measurements were recorded prior to and during pregnancy. At gestational day 
22, hourly checks were made for signs of parturition and following birth of the 5th pup each rat dam was imme-
diately euthanized by CO2 asphyxiation and cervical dislocation. Pups were euthanased by overdose of pento-
barbitone and cervical dislocation. Maternal blood was immediately collected via cardiac puncture into EDTA 
coated tubes (Sarstedt, Nümbrecht, Germany), and subsequently centrifuged at 13,000 rpm and the plasma snap 
frozen in liquid nitrogen and stored at −80 °C. The uterus, liver, gonadal and perineal fat depots were dissected 
out, weighed, snap frozen in liquid nitrogen and stored at −80 °C for future analysis.
Lipid Extraction. Prior to lipid extraction, liver and uterine tissue was crushed into a fine powder under liq-
uid nitrogen, using a mortar and pestle. A total of 300 mg of crushed rat liver or uterine horn was homogenised in 
2 mls of ice-cold 0.9% saline in 30-second bursts. The homogenate was then vortexed in 3 ml 99.9% Propan-2-ol, 
and left to incubate at room temperature for 5 minutes. After the 5 min incubation period, 6 ml of 98% chloroform 
was added to the solution, inverted, and centrifuged at 3000 rpm for 10 minutes. Following centrifugation, the 
chloroform layer was transferred into a fresh tube using a disposable glass pipette and dried under nitrogen gas 
at 37 °C. Once evaporated, samples were then reconstituted in either 500 μl (liver) or 100 μl (uterine horn) 9:1 
Chloroform: Methanol, and 20 μl of this solution was then pipetted onto PUFA COATTM collection cards47 for 
fatty acid analysis.
Constituents Amount (g/kg)
Corn oil 100
Casein 200
Maize starch 218
Butter 295
Sucrose 100
Cellulose 50
Vitamin mix 5
Mineral mix 20
Methionine 10
Choline 2
Cholesterol 10
Table 4. Detailed breakdown of ingredients used to produce 1 kg of HFHC diet. (Note that cholesterol was 
dissolved within in the 100 ml vegetable oil).
Nutritional Breakdown CONTROL HFHC
Energy density (Kcal/g) 3.1 5.26
Total available carbohydrates (%) 58.9 30.5
Total protein (%) 18.6 18.5
Total fat (%) 6.2 35.6
Total fibre (%) 3.5 4.8
Total ash (%) 5.3 1.9
Total moisture 7.5 8.8
Table 5. Nutritional breakdown of the CONTROL chow and HFHC diet. Nutritional analysis was carried by 
Scientific Laboratory Services (SAL) Ltd. UK.
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Lipid Analysis. All samples were analysed for their fatty acid profile using a gas chromatography flame ioni-
sation detector (GC-FID) as described previously by Liu et al.47.
Statistical Analysis. All the data were analysed using the Statistical Package for Social Science (Version 21; 
SPSS Inc, Chicago, IL, USA). The homogeneity of the data was assessed and if not normally distributed appropri-
ately transformed to achieve normal distribution. To determine the effect of maternal obesity and change of diet 
at conception on the plasma, hepatic and uterine fatty acid composition during labour the statistical test used was 
one-way ANOVA, with LSD post-hoc tests to determine difference between individual treatment groups where 
the ANOVA revealed significant differences between groups. All data are expressed as the mean value ± SEM and 
P = ≤0.05 was considered statistically significant.
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